The New FISH: Welcome to Cytogenetics 2.0

In a recent article for Clinical Lab Products, Brian Kirk, VP for Business Development at BioDot, writes about how #cytogenetics has been transformed for the future through the latest in fluorescence in situ hybridization #FISH technology. CellWriter technology from BioDot brings FISH workflows into the 21st century, creating a simple, cost-effective, and automated process for cytogenetics labs.

View Article